G Sturfelt

Systemic Lupus Erythematosus and Infection: A Controlled and Prospective Study Including an Epidemiological Group

Ola Nived, G Sturfelt, Frank A. Wollheim · QJM · 1985 · 116 citations

Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells

Birgitta Gullstrand, Ulla Mårtensson, G Sturfelt et al. · Clinical & Experimental Immunology · 2009 · 106 citations · Full text

A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus

Elisabet Svenungsson, Dag Leonard, Johanna K. Sandling et al. · Annals of the Rheumatic Diseases · 2009 · 81 citations

Synergetic effect between interleukin-1 receptor antagonist allele (IL1RN*2) and MHC class II (DR17,DQ2) in determining susceptibility to systemic lupus erythematosus

Fredrik Tjernström, G. HELLMER, O Nived et al. · Lupus · 1999 · 56 citations

Race/ethnicity and cancer occurrence in systemic lupus erythematosus

Sasha Bernatsky, J.‐F. Boivin, L. Joseph et al. · Arthritis Care & Research · 2005 · 51 citations · Full text